Clari Vest Asset Management LLC Neurocrine Biosciences Inc Transaction History

Clari Vest Asset Management LLC

$1 Billion
Q3 2024

A detailed history of Clari Vest Asset Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 9,613 shares of NBIX stock, worth $978,026. This represents 0.11% of its overall portfolio holdings.

Number of Shares

9,613

Previous 9,613 -0.0%

Holding current value

$978,026

Previous $1.32 Million 16.4%

% of portfolio

0.11%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$130.86 - $143.19 $2,486 - $2,720	19 Added 0.2%	9,613 $1.32 Million
Q1 2024 May 06, 2024	SELL	$130.4 - $143.74 $10,301 - $11,355	-79 Reduced 0.82%	9,594 $1.32 Million
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $318 - $398	-3 Reduced 0.03%	9,673 $1.27 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $1,410 - $1,756	15 Added 0.16%	9,676 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $179,418 - $210,159	-2,004 Reduced 17.18%	9,661 $911,000
Q1 2023 May 08, 2023	SELL	$94.11 - $123.02 $1,129 - $1,476	-12 Reduced 0.1%	11,665 $1.18 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $4,695 - $5,590	-44 Reduced 0.38%	11,677 $1.39 Million
Q3 2022 Nov 10, 2022	SELL	$92.03 - $107.81 $334,897 - $392,320	-3,639 Reduced 23.69%	11,721 $1.25 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $303,160 - $400,280	-4,000 Reduced 20.66%	15,360 $1.5 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $151,335 - $201,818	-1,900 Reduced 8.94%	19,360 $1.65 Million
Q3 2021 Nov 08, 2021	SELL	$86.18 - $99.03 $43,090 - $49,515	-500 Reduced 2.3%	21,260 $2.04 Million
Q1 2021 May 13, 2021	SELL	$87.57 - $119.4 $17,514 - $23,880	-200 Reduced 0.91%	21,760 $2.12 Million
Q4 2020 Feb 09, 2021	SELL	$86.91 - $108.33 $17,382 - $21,666	-200 Reduced 0.9%	21,960 $2.11 Million
Q3 2020 Nov 09, 2020	SELL	$96.16 - $135.15 $44,233 - $62,169	-460 Reduced 2.03%	22,160 $2.13 Million
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $1.02 Million - $1.57 Million	12,020 Added 113.4%	22,620 $2.76 Million
Q1 2020 May 04, 2020	BUY	$75.11 - $113.76 $796,166 - $1.21 Million	10,600 New	10,600 $918,000
Q2 2018 Aug 10, 2018	SELL	$75.3 - $105.99 $1.06 Million - $1.49 Million	-14,015 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$75.88 - $92.43 $7,588 - $9,243	100 Added 0.72%	14,015 $1.16 Million
Q4 2017 Feb 13, 2018	SELL	$58.53 - $77.59 $901,244 - $1.19 Million	-15,398 Reduced 52.53%	13,915 $1.08 Million
Q2 2017 Nov 20, 2017	BUY	N/A	29,313	29,313 $1.35 Million

Others Institutions Holding NBIX

# of Institutions

652

Shares Held

95.9M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $9.73B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Account

Clari Vest Asset Management LLC Neurocrine Biosciences Inc Transaction History